Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1556931rdf:typepubmed:Citationlld:pubmed
pubmed-article:1556931lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0009924lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0060240lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0024488lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0563532lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C1450054lld:lifeskim
pubmed-article:1556931lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:1556931pubmed:issue1lld:pubmed
pubmed-article:1556931pubmed:dateCreated1992-5-7lld:pubmed
pubmed-article:1556931pubmed:abstractTextSuperparamagnetic iron oxide particles, a new class of contrast agents for MRI, are extremely good enhancers of proton relaxation. However, the development of such particle systems has resulted in a wide range of preparations whose physico-chemical properties differ greatly. We have conducted a set of physical experiments: X ray diffraction analysis, relaxivity measurements, susceptibility determinations, and thermomagnetic cycling on different preparations of superparamagnetic particles. Our results demonstrate a good correlation between susceptibilities measured in liquid samples at room temperature and the R2/R1 ratio. Susceptibility measurements between liquid nitrogen temperature and room temperature show three different types of behavior dependent on the size of iron oxide crystals. Comparison of heating and cooling curves from strong field thermomagnetic cycles provides information about the maghemite/magnetite crystal content. The information on magnetic properties reported in this study may help to characterize and to select these materials for use as MRI contrast agents.lld:pubmed
pubmed-article:1556931pubmed:languageenglld:pubmed
pubmed-article:1556931pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:citationSubsetIMlld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1556931pubmed:statusMEDLINElld:pubmed
pubmed-article:1556931pubmed:monthMarlld:pubmed
pubmed-article:1556931pubmed:issn0740-3194lld:pubmed
pubmed-article:1556931pubmed:authorpubmed-author:JalletPPlld:pubmed
pubmed-article:1556931pubmed:authorpubmed-author:PerroudHHlld:pubmed
pubmed-article:1556931pubmed:authorpubmed-author:Le JeuneJ JJJlld:pubmed
pubmed-article:1556931pubmed:authorpubmed-author:PouliquenDDlld:pubmed
pubmed-article:1556931pubmed:authorpubmed-author:CalzaFFlld:pubmed
pubmed-article:1556931pubmed:issnTypePrintlld:pubmed
pubmed-article:1556931pubmed:volume24lld:pubmed
pubmed-article:1556931pubmed:ownerNLMlld:pubmed
pubmed-article:1556931pubmed:authorsCompleteYlld:pubmed
pubmed-article:1556931pubmed:pagination75-84lld:pubmed
pubmed-article:1556931pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:meshHeadingpubmed-meshheading:1556931-...lld:pubmed
pubmed-article:1556931pubmed:year1992lld:pubmed
pubmed-article:1556931pubmed:articleTitleInvestigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.lld:pubmed
pubmed-article:1556931pubmed:affiliationLaboratoire de Biophysique, Faculté de Médecine, Angers, France.lld:pubmed
pubmed-article:1556931pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1556931pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1556931pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1556931lld:pubmed